Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00379_DB00382_nanopub.RAbrRRysVicCJVtrWeLotlcioirmmVFvi5x7PHMQyt9rU#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00379_DB00382 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00379_DB00382 label "DDI between Mexiletine and Tacrine - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Mexiletine. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Mexiletine is initiated, discontinued or if the dose is changed. [drugbank_resource:DB00379_DB00382]" assertion.
- drugbank_resource:DB00379_DB00382 identifier "drugbank_resource:DB00379_DB00382" assertion.
- drugbank_resource:DB00379_DB00382 title "DDI between Mexiletine and Tacrine - The metabolism of Tacrine, a CYP1A2 substrate, may be reduced by strong CYP1A2 inhibitors such as Mexiletine. Consider modifying therapy to avoid Tacrine toxicity. Monitor the efficacy and toxicity of Tacrine if Mexiletine is initiated, discontinued or if the dose is changed." assertion.
- drugbank:DB00382 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00379_DB00382 assertion.
- drugbank:DB00379 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00379_DB00382 assertion.